BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 33980594)

  • 1. Inhibition of Antiviral Innate Immunity by Foot-and-Mouth Disease Virus L
    Sui C; Jiang D; Wu X; Liu S; Li F; Pan L; Cong X; Li J; Yoo D; Rock DL; Miller LC; Lee C; Du Y; Qi J
    J Virol; 2021 Jul; 95(15):e0036121. PubMed ID: 33980594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment of the DeISGylation Activity of Foot-and-Mouth Disease Virus Lpro Causes Attenuation
    Medina GN; Azzinaro P; Ramirez-Medina E; Gutkoska J; Fang Y; Diaz-San Segundo F; de Los Santos T
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32295921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Foot-and-Mouth Disease Virus Antagonizes NOD2-Mediated Antiviral Effects by Inhibiting NOD2 Protein Expression.
    Liu H; Zhu Z; Xue Q; Yang F; Cao W; Zhang K; Liu X; Zheng H
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30894473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate immune sensor LGP2 is cleaved by the Leader protease of foot-and-mouth disease virus.
    Rodríguez Pulido M; Sánchez-Aparicio MT; Martínez-Salas E; García-Sastre A; Sobrino F; Sáiz M
    PLoS Pathog; 2018 Jun; 14(6):e1007135. PubMed ID: 29958302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Foot-and-mouth disease virus 3C protease cleaves NEMO to impair innate immune signaling.
    Wang D; Fang L; Li K; Zhong H; Fan J; Ouyang C; Zhang H; Duan E; Luo R; Zhang Z; Liu X; Chen H; Xiao S
    J Virol; 2012 Sep; 86(17):9311-22. PubMed ID: 22718831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rotavirus Controls Activation of the 2'-5'-Oligoadenylate Synthetase/RNase L Pathway Using at Least Two Distinct Mechanisms.
    Sánchez-Tacuba L; Rojas M; Arias CF; López S
    J Virol; 2015 Dec; 89(23):12145-53. PubMed ID: 26401041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3Cpro of foot-and-mouth disease virus antagonizes the interferon signaling pathway by blocking STAT1/STAT2 nuclear translocation.
    Du Y; Bi J; Liu J; Liu X; Wu X; Jiang P; Yoo D; Zhang Y; Wu J; Wan R; Zhao X; Guo L; Sun W; Cong X; Chen L; Wang J
    J Virol; 2014 May; 88(9):4908-20. PubMed ID: 24554650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foot-and-Mouth Disease Virus Viroporin 2B Antagonizes RIG-I-Mediated Antiviral Effects by Inhibition of Its Protein Expression.
    Zhu Z; Wang G; Yang F; Cao W; Mao R; Du X; Zhang X; Li C; Li D; Zhang K; Shu H; Liu X; Zheng H
    J Virol; 2016 Dec; 90(24):11106-11121. PubMed ID: 27707918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foot-and-Mouth Disease Virus Leader Protease Cleaves G3BP1 and G3BP2 and Inhibits Stress Granule Formation.
    Visser LJ; Medina GN; Rabouw HH; de Groot RJ; Langereis MA; de Los Santos T; van Kuppeveld FJM
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30404792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional roles of leader protein of foot-and-mouth disease viruses in suppressing host antiviral responses.
    Liu Y; Zhu Z; Zhang M; Zheng H
    Vet Res; 2015 Oct; 46():127. PubMed ID: 26511922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evading the host immune response: how foot-and-mouth disease virus has become an effective pathogen.
    Grubman MJ; Moraes MP; Diaz-San Segundo F; Pena L; de los Santos T
    FEMS Immunol Med Microbiol; 2008 Jun; 53(1):8-17. PubMed ID: 18400012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between FMDV L
    Medina GN; Knudsen GM; Greninger AL; Kloc A; Díaz-San Segundo F; Rieder E; Grubman MJ; DeRisi JL; de Los Santos T
    Virology; 2017 May; 505():12-22. PubMed ID: 28219017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay of foot and mouth disease virus with cell-mediated and humoral immunity of host.
    Abubakar M; Manzoor S; Ahmed A
    Rev Med Virol; 2018 Mar; 28(2):. PubMed ID: 29282795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rotavirus NSP1 Subverts the Antiviral Oligoadenylate Synthetase-RNase L Pathway by Inducing RNase L Degradation.
    Dai J; Yi G; Philip AA; Patton JT
    mBio; 2022 Dec; 13(6):e0299522. PubMed ID: 36413023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-Inducible Oligoadenylate Synthetase-Like Protein Acts as an Antiviral Effector against Classical Swine Fever Virus via the MDA5-Mediated Type I Interferon-Signaling Pathway.
    Li LF; Yu J; Zhang Y; Yang Q; Li Y; Zhang L; Wang J; Li S; Luo Y; Sun Y; Qiu HJ
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Foot-and-Mouth Disease Virus Evades Innate Immune Response by 3C-Targeting of MDA5.
    Kim H; Kim AY; Choi J; Park SY; Park SH; Kim JS; Lee SI; Park JH; Park CK; Ko YJ
    Cells; 2021 Jan; 10(2):. PubMed ID: 33572945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Foot-and-Mouth Disease Virus 3B Protein Interacts with Pattern Recognition Receptor RIG-I to Block RIG-I-Mediated Immune Signaling and Inhibit Host Antiviral Response.
    Zhang X; Zhu Z; Wang C; Yang F; Cao W; Li P; Du X; Zhao F; Liu X; Zheng H
    J Immunol; 2020 Oct; 205(8):2207-2221. PubMed ID: 32917788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response.
    de Los Santos T; de Avila Botton S; Weiblen R; Grubman MJ
    J Virol; 2006 Feb; 80(4):1906-14. PubMed ID: 16439546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basal Level p53 Suppresses Antiviral Immunity against Foot-and-Mouth Disease Virus.
    Zhang T; Chen H; Liu X; Qi L; Gao X; Wang K; Yao K; Zhang J; Sun Y; Zhang Y; Wu R
    Viruses; 2019 Aug; 11(8):. PubMed ID: 31394868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of RNase L in Egyptian Rousette Bat-Derived RoNi/7 Cells Is Dependent Primarily on OAS3 and Independent of MAVS Signaling.
    Li Y; Dong B; Wei Z; Silverman RH; Weiss SR
    mBio; 2019 Nov; 10(6):. PubMed ID: 31719180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.